Structural studies on porphobilinogen deaminase. 1994

R Lambert, and P D Brownlie, and S C Woodcock, and G V Louie, and J C Cooper, and M J Warren, and P M Jordan, and T L Blundell, and S P Wood
Department of Crystallography, Birkbeck College, London, UK.

The X-ray crystallographic analysis of porphobilinogen deaminase (hydroxymethylbilane synthase, EC 4.3.1.8) shows the polypeptide chain folded into three domains, (1) N-terminal, (2) central and (3) C-terminal, of approximately equal size. Domains 1 and 2 have a similar overall topology, a modified doubly wound parallel beta-sheet. Domain 3 is an open-faced three-stranded antiparallel beta-sheet, with one face covered by three alpha-helices. The active site is located between domains 1 and 2. The dipyrromethane cofactor linked to cysteine 242 protrudes from domain 3 into the mouth of the cleft. Flexible segments between domains 1 and 2 are thought to have a role in a hinge mechanism, facilitating conformational changes. The cleft is lined with positively charged, highly conserved, arginine residues which form ion pairs with the acidic side chains of the cofactor. Aspartic acid 84 has been identified as a critical catalytic residue both by its proximity to the cofactor pyrrole ring nitrogen and by structural and kinetic studies of the Asp-84-->Glu mutant protein. The active site arginine residues have been altered by site-directed mutagenesis to histidine residues. The mutant proteins have been studied crystallographically in order to reconcile the functional changes in the polymerization reaction with structural changes in the enzyme.

UI MeSH Term Description Entries
D011163 Hydroxymethylbilane Synthase An enzyme that catalyzes the tetrapolymerization of the monopyrrole PORPHOBILINOGEN into the hydroxymethylbilane preuroporphyrinogen (UROPORPHYRINOGENS) in several discrete steps. It is the third enzyme in the 8-enzyme biosynthetic pathway of HEME. In humans, deficiency in this enzyme encoded by HMBS (or PBGD) gene results in a form of neurological porphyria (PORPHYRIA, ACUTE INTERMITTENT). This enzyme was formerly listed as EC 4.3.1.8 Porphobilinogen Ammonia-Lyase,Porphobilinogen Deaminase,Uroporphyrinogen I Synthase,Hydroxymethylbilane Synthetase,Pre-uroporphyrinogen Synthetase,Preuroporphyrinogen Synthetase,Ammonia-Lyase, Porphobilinogen,Deaminase, Porphobilinogen,Porphobilinogen Ammonia Lyase,Pre uroporphyrinogen Synthetase,Synthase, Hydroxymethylbilane,Synthase, Uroporphyrinogen I,Synthetase, Hydroxymethylbilane,Synthetase, Pre-uroporphyrinogen,Synthetase, Preuroporphyrinogen
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D016297 Mutagenesis, Site-Directed Genetically engineered MUTAGENESIS at a specific site in the DNA molecule that introduces a base substitution, or an insertion or deletion. Mutagenesis, Oligonucleotide-Directed,Mutagenesis, Site-Specific,Oligonucleotide-Directed Mutagenesis,Site-Directed Mutagenesis,Site-Specific Mutagenesis,Mutageneses, Oligonucleotide-Directed,Mutageneses, Site-Directed,Mutageneses, Site-Specific,Mutagenesis, Oligonucleotide Directed,Mutagenesis, Site Directed,Mutagenesis, Site Specific,Oligonucleotide Directed Mutagenesis,Oligonucleotide-Directed Mutageneses,Site Directed Mutagenesis,Site Specific Mutagenesis,Site-Directed Mutageneses,Site-Specific Mutageneses
D018360 Crystallography, X-Ray The study of crystal structure using X-RAY DIFFRACTION techniques. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) X-Ray Crystallography,Crystallography, X Ray,Crystallography, Xray,X Ray Crystallography,Xray Crystallography,Crystallographies, X Ray,X Ray Crystallographies

Related Publications

R Lambert, and P D Brownlie, and S C Woodcock, and G V Louie, and J C Cooper, and M J Warren, and P M Jordan, and T L Blundell, and S P Wood
January 1976, Acta physiologica latino americana,
R Lambert, and P D Brownlie, and S C Woodcock, and G V Louie, and J C Cooper, and M J Warren, and P M Jordan, and T L Blundell, and S P Wood
January 1991, Zeitschrift fur Naturforschung. C, Journal of biosciences,
R Lambert, and P D Brownlie, and S C Woodcock, and G V Louie, and J C Cooper, and M J Warren, and P M Jordan, and T L Blundell, and S P Wood
July 1997, Biochemistry and molecular biology international,
R Lambert, and P D Brownlie, and S C Woodcock, and G V Louie, and J C Cooper, and M J Warren, and P M Jordan, and T L Blundell, and S P Wood
February 1995, Nihon rinsho. Japanese journal of clinical medicine,
R Lambert, and P D Brownlie, and S C Woodcock, and G V Louie, and J C Cooper, and M J Warren, and P M Jordan, and T L Blundell, and S P Wood
November 2004, Nihon rinsho. Japanese journal of clinical medicine,
R Lambert, and P D Brownlie, and S C Woodcock, and G V Louie, and J C Cooper, and M J Warren, and P M Jordan, and T L Blundell, and S P Wood
September 1999, Nihon rinsho. Japanese journal of clinical medicine,
R Lambert, and P D Brownlie, and S C Woodcock, and G V Louie, and J C Cooper, and M J Warren, and P M Jordan, and T L Blundell, and S P Wood
September 2018, Biochimica et biophysica acta. General subjects,
R Lambert, and P D Brownlie, and S C Woodcock, and G V Louie, and J C Cooper, and M J Warren, and P M Jordan, and T L Blundell, and S P Wood
June 1974, Biochimica et biophysica acta,
R Lambert, and P D Brownlie, and S C Woodcock, and G V Louie, and J C Cooper, and M J Warren, and P M Jordan, and T L Blundell, and S P Wood
November 2017, Acta crystallographica. Section F, Structural biology communications,
R Lambert, and P D Brownlie, and S C Woodcock, and G V Louie, and J C Cooper, and M J Warren, and P M Jordan, and T L Blundell, and S P Wood
January 1981, The International journal of biochemistry,
Copied contents to your clipboard!